Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor.

Chronic hypoxia is one of the main causes of pulmonary hypertension (PH) associated with ROS production. Lectin-like oxidized low-density lipoprotein receptor (LOX)-1 is known to be an endothelial receptor of oxidized low-density lipoprotein, which is assumed to play a role in the initiation of ROS generation. We investigated the role of LOX-1 and ROS generation in PH and vascular remodeling in LOX-1 transgenic (TG) mice. We maintained 8- to 10-wk-old male LOX-1 TG mice and wild-type (WT) mice in normoxia (room air) or hypoxia (10% O2 chambers) for 3 wk. Right ventricular (RV) systolic pressure (RVSP) was comparable between the two groups under normoxic conditions; however, chronic hypoxia significantly increased RVSP and RV hypertrophy in LOX-1 TG mice compared with WT mice. Medial wall thickness of the pulmonary arteries was significantly greater in LOX-1 TG mice than in WT mice. Furthermore, hypoxia enhanced ROS production and nitrotyrosine expression in LOX-1 TG mice, supporting the observed pathological changes. Administration of the NADPH oxidase inhibitor apocynin caused a significant reduction in PH and vascular remodeling in LOX-1 TG mice. Our results suggest that LOX-1-ROS generation induces the development and progression of PH.

[1]  V. Demarco,et al.  Contribution of oxidative stress to pulmonary arterial hypertension. , 2010, World journal of cardiology.

[2]  Gene Kim,et al.  Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension: A Basis for Excessive Cell Proliferation and a New Therapeutic Target , 2010, Circulation.

[3]  M. Fujita,et al.  Left ventricular expression of lectin-like oxidized low-density lipoprotein receptor-1 in failing rat hearts. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[4]  H. Morawietz,et al.  Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose. , 2010, European journal of pharmacology.

[5]  T. Sawamura,et al.  Lox-1: the multifunctional receptor underlying cardiovascular dysfunction. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[6]  Y. Takeishi,et al.  LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells. , 2009, Cardiovascular research.

[7]  Y. Takeishi,et al.  Role of LOX‐1 in monocyte adhesion‐triggered redox, Akt/eNOS and Ca2+ signaling pathways in endothelial cells , 2009, Journal of cellular physiology.

[8]  A. Malik,et al.  Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. , 2009, The Journal of clinical investigation.

[9]  Songwen Zhang,et al.  CRP is a novel ligand for the oxidized LDL receptor LOX-1. , 2009, American journal of physiology. Heart and circulatory physiology.

[10]  R. Pawliczak,et al.  Apocynin: Molecular Aptitudes , 2008, Mediators of inflammation.

[11]  V. Demarco,et al.  Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat. , 2008, American journal of physiology. Heart and circulatory physiology.

[12]  Pengfei Wu,et al.  LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes. , 2008, American journal of physiology. Renal physiology.

[13]  T. Tokudome,et al.  Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious rats. , 2008, Endocrinology.

[14]  J. Mehta,et al.  LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion. , 2007, Cardiovascular research.

[15]  H. Kawachi,et al.  Podocyte as the Target for Aldosterone: Roles of Oxidative Stress and Sgk1 , 2007, Hypertension.

[16]  R. Folz,et al.  Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox). , 2006, American journal of physiology. Lung cellular and molecular physiology.

[17]  J. Mehta,et al.  Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model. , 2006, Cardiovascular research.

[18]  T. Kita,et al.  Overexpression of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Induces Intramyocardial Vasculopathy in Apolipoprotein E–Null Mice , 2005, Circulation research.

[19]  J. Loscalzo,et al.  Pulmonary arterial hypertension , 2006, The New England journal of medicine.

[20]  T. Sawamura,et al.  Induction of Endothelin-1 Production in Endothelial Cells Via Co-Operative Action Between CD40 and Lectin-like Oxidized LDL Receptor (LOX-1) , 2004, Journal of cardiovascular pharmacology.

[21]  A. Krettek,et al.  Hypoxia Increases LDL Oxidation and Expression of 15-Lipoxygenase-2 in Human Macrophages , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[22]  T. Fujita,et al.  Adrenomedullin Can Protect Against Pulmonary Vascular Remodeling Induced by Hypoxia , 2004, Circulation.

[23]  H. Shin,et al.  Remnant Lipoprotein Particles Induce Apoptosis in Endothelial Cells by NAD(P)H Oxidase–Mediated Production of Superoxide and Cytokines via Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Activation: Prevention by Cilostazol , 2004, Circulation.

[24]  T. Masaki.  Endothelial dysfunction and LOX-1: forty years from muscle to endothelium. , 2003, Circulation research.

[25]  Kayo Nakamura,et al.  Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Mehta,et al.  LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation. , 2002, American journal of physiology. Heart and circulatory physiology.

[27]  M. Humbert,et al.  Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension , 2002, Nature Medicine.

[28]  T. Sawamura,et al.  LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. , 2002, Pharmacology & therapeutics.

[29]  J. Mehta,et al.  Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. , 2002, Journal of the American College of Cardiology.

[30]  Avid,et al.  BOSENTAN THERAPY FOR PULMONARY ARTERIAL HYPERTENSION , 2002 .

[31]  G. Christ,et al.  Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. , 2001, The Journal of biological chemistry.

[32]  J. Mehta,et al.  Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. , 2001, Cardiovascular research.

[33]  M. Drab,et al.  Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice , 2001, Science.

[34]  T. Sawamura,et al.  The Binding of Oxidized Low Density Lipoprotein (ox-LDL) to ox-LDL Receptor-1 Reduces the Intracellular Concentration of Nitric Oxide in Endothelial Cells through an Increased Production of Superoxide* , 2001, The Journal of Biological Chemistry.

[35]  N. Voelkel,et al.  Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. , 2001, Journal of applied physiology.

[36]  M. Bitzer,et al.  Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I Receptor* , 2001, The Journal of Biological Chemistry.

[37]  J. Mehta,et al.  Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan. , 2000, Biochemical and biophysical research communications.

[38]  J. Mehta,et al.  Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. , 2000, Circulation.

[39]  J. Mehta,et al.  Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[40]  J. Mehta,et al.  Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. , 1999, Circulation research.

[41]  J. Ando,et al.  Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. , 1998, Circulation research.

[42]  T. Kita,et al.  Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. , 1998, Circulation research.

[43]  T. Kita,et al.  Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  T. Kita,et al.  An endothelial receptor for oxidized low-density lipoprotein , 1997, Nature.

[45]  D. Stewart,et al.  Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.

[46]  B. Groves,et al.  An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. , 1992, The New England journal of medicine.

[47]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.